Chiron Real Estate grants CDO 23,855 stock options
Rhea-AI Filing Summary
Chiron Real Estate Inc. (XRN) reported that officer Robert Harold Zeiller, Chief Development Officer and Head of Seniors Housing, received a grant of options to acquire 23,855 shares of common stock at an exercise price of $60.00 per share. These options vest in three equal annual installments on August 27, 2027, 2028 and 2029, contingent on continued service, and expire on August 27, 2036. The grant was made outside Chiron Real Estate Inc.'s 2016 Equity Incentive Plan as an employment inducement award under NYSE Listing Rule 303A.08, approved by the board’s Compensation Committee of independent directors.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Zeiller Robert Harold
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option (Right to buy) F1, F2 | 23,855 | $0.00 | $0.00 |
Holdings After Transaction:
Option (Right to buy) — 23,855 shares (Direct)
Footnotes (2)
- F1. The options have an exercise price of $60.00 per share and the shares subject to the options become exercisable in three equal annual installments on each of August 27, 2027, August 27, 2028 and August 27, 2029, subject to the Reporting Person's continued service through each applicable vesting date.
- F2. The options were granted outside of the Issuer's 2016 Equity Incentive Plan as an employment inducement award under New York Stock Exchange Listing Rule 303A.08 and as a material inducement to the Reporting Person entering into employment with the Issuer. The awards were approved by the Compensation Committee of the Board of Directors, consisting solely of independent directors, in reliance on the employment inducement exemption under NYSE Listing Rule 303A.08.
Key Figures
Options granted: 23,855 options
Exercise price: $60.00 per share
Expiration date: August 27, 2036
+2 more
5 metrics
Options granted
23,855 options
Grant of options to acquire common stock on 2026-08-27
Exercise price
$60.00 per share
Exercise price for options granted to Robert Harold Zeiller
Expiration date
August 27, 2036
Option term end for the inducement grant
Underlying shares
23,855 shares
Common stock underlying the options granted
Vesting schedule
Three equal annual installments
Vesting on August 27, 2027, 2028 and 2029
Key Terms
employment inducement award, NYSE Listing Rule 303A.08, exercise price, vesting, +1 more
5 terms
employment inducement award financial
"The options were granted outside of the Issuer's 2016 Equity Incentive Plan as an employment inducement award"
An employment inducement award is a grant of company stock, options, or other equity given to a new hire as a joining bonus to encourage them to work for the company. Like a signing bonus in cash, it ties the employee’s pay to the company’s future value and often vests over time. Investors care because these awards increase outstanding shares and compensation costs, affecting per‑share value and motivating executives to meet performance goals.
NYSE Listing Rule 303A.08 regulatory
"under New York Stock Exchange Listing Rule 303A.08 and as a material inducement"
exercise price financial
"The options have an exercise price of $60.00 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to the options become exercisable in three equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
independent directors regulatory
"approved by the Compensation Committee of the Board of Directors, consisting solely of independent directors"
Members of a company’s board who do not have significant business, family, or financial ties to the company and are not part of its management; they are chosen to provide impartial oversight of strategy, financial reporting, executive pay and risk. They matter to investors because independent directors act like an objective referee, helping ensure decisions favor shareholders’ long-term interests rather than insiders, which can strengthen trust and reduce the chance of mismanagement or conflicts of interest.
FAQ
What equity award did XRN grant to Robert Harold Zeiller?
Chiron Real Estate Inc. granted Robert Harold Zeiller options over 23,855 shares of common stock with an exercise price of $60.00 per share, expiring on August 27, 2036, as part of his employment package.
How do the new XRN stock options for Robert Harold Zeiller vest?
The options for 23,855 shares vest in three equal annual installments on August 27, 2027, August 27, 2028 and August 27, 2029, subject to Robert Harold Zeiller’s continued service through each vesting date.
What is the exercise price and term of the new XRN options?
The options granted to Robert Harold Zeiller have an exercise price of $60.00 per share and an expiration date of August 27, 2036, giving him the right to purchase XRN common stock at that price until that date, subject to vesting.
Were the XRN options granted under the 2016 Equity Incentive Plan?
No. The options were granted outside Chiron Real Estate Inc.’s 2016 Equity Incentive Plan as an employment inducement award under NYSE Listing Rule 303A.08 to induce Robert Harold Zeiller to enter into employment.
Who approved the employment inducement option grant at XRN?
The employment inducement option grant to Robert Harold Zeiller was approved by Chiron Real Estate Inc.’s Compensation Committee of the Board of Directors, which consists solely of independent directors, relying on the exemption under NYSE Listing Rule 303A.08.
AI-generated analysis. How Rhea-AI works. Not financial advice.
